Medicare's Coverage of Alzheimer's Drugs: What You Need to Know
TL;DR Summary
Medicare will now pay for new Alzheimer's drugs that receive full approval from the FDA, instead of only covering them for patients enrolled in clinical trials. Physicians will be required to collect data on how well the drugs perform in the real world. The change is a win for advocacy groups seeking broader access to newer medications that have shown signs of slowing the progression of the disease. Two drugs have been granted accelerated approval: Biogen's Aduhelm and Eisai's Leqembi.
- New Alzheimer's drugs to be covered by Medicare, if FDA approved NBC News
- Medicare to cover Alzheimer’s drug class that includes Leqembi The Washington Post
- Medicare details plan to cover Alzheimer's treatments CNBC
- Medicare will limit coverage of Alzheimer’s drugs The Hill
- Medicare Will Pay for Alzheimer's Therapies, but With a Big Requirement Barron's
Reading Insights
Total Reads
0
Unique Readers
7
Time Saved
2 min
vs 3 min read
Condensed
82%
448 → 80 words
Want the full story? Read the original article
Read on NBC News